US Asset Management LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Hold |
507
| – | – | 0.2% | 115 |
|
|
2025
Q1 | $246K | Hold |
507
| – | – | 0.23% | 109 |
|
|
2024
Q4 | $204K | Hold |
507
| – | – | 0.18% | 119 |
|
|
2024
Q3 | $251K | Hold |
507
| – | – | 0.22% | 103 |
|
|
2024
Q2 | $238K | Sell |
507
-26
| -5% | -$12.2K | 0.21% | 116 |
|
|
2024
Q1 | $223K | Sell |
533
-4
| -0.7% | -$1.67K | 0.2% | 123 |
|
|
2023
Q4 | $218K | Buy |
+537
| New | +$218K | 0.22% | 120 |
|
|
2023
Q2 | – | Sell |
-542
| Closed | -$171K | – | 226 |
|
|
2023
Q1 | $171K | Hold |
542
| – | – | 0.17% | 128 |
|
|
2022
Q4 | $157K | Buy |
+542
| New | +$157K | 0.17% | 139 |
|
|
2022
Q2 | $153K | Hold |
542
| – | – | 0.17% | 138 |
|
|
2022
Q1 | $141K | Buy |
+542
| New | +$141K | 0.13% | 146 |
|
|
2021
Q4 | – | Sell |
-542
| Closed | -$98K | – | 231 |
|
|
2021
Q3 | $98K | Buy |
+542
| New | +$98K | 0.1% | 160 |
|